Another late-breaker presented here was the appropriately named CHICAGO Study, in which 462 patients with type 2 diabetes were randomly selected at Chicago heart clinics to receive treatment with pioglitazone or with glimepriride.
Early mortality rates for ST-segment elevation myocardial infarction in randomized trials have decreased dramatically over the past 20 years, from 13-percent one-month mortality in 1986 to less than 4 percent today.
Logic would hold that an occluded infarct-related artery should be open before the patient is discharged. But the chair of the Occluded Artery Trial (OAT) presented data here showing that stable patients undergoing routine PCI for occluded arteries three to 28 days after MI had virtually the same number of major cardiovascular events as similar patients receiving medication alone.
Making merry is often synonymous with overindulging — whether from holiday feasts or rich desserts or alcoholic beverages — ringing in the holiday season as “heartburn season.”
Over the last several years angioplasty has exceeded coronary bypass surgery as the preferred way to treat coronary artery disease. The stents, narrow tubes inserted into the artery to facilitate blood flow, commonly used in the procedure are less invasive than open-heart surgery and offer greater convenience to the patient and the ability to perform more complex procedures.
Erectile dysfunction (ED) medications known as Phosphodiesterase type 5 (PDE-5) inhibitors have been used by millions of men as safe and effective management options associated with high rates of patient and partner satisfaction.
Robert Kass, Ph.D., chairman of the department of Pharmacology at Columbia University Medical Center , will present the latest research on the discovery of a potential molecular culprit for atrial fibrillation (AF), the most common arrhythmias in the human heart, which can be a precursor for stroke.
A new lab-on-a-chip can identify single bacterial cells for the most common cases of drug-resistant pneumonia, cutting down the wait from days to hours for identifying the particular strain and treating it.
About one-third of heart attack patients do not receive treatment to open blocked arteries within the recommended 12-hour timeframe after a heart attack. Treatment such as angioplasty or clot-busting drugs may not be given because patients arrive at the hospital too late.
In the days following a heart attack, patients who have no or mild symptoms and undergo a procedure called angioplasty to mechanically open their totally blocked coronary arteries do not reduce their risk of having another heart attack, going into heart failure or dying, according to the results of a new study.